financetom
Business
financetom
/
Business
/
First Majestic to Buy Gatos Silver for US$970 Million
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
First Majestic to Buy Gatos Silver for US$970 Million
Sep 6, 2024 12:56 PM

07:50 AM EDT, 09/05/2024 (MT Newswires) -- First Majestic Silver ( AG ) said on Thursday that it will acquire Gatos Silver ( GATO ) for US$970 million.

The companies said the transaction would consolidate the Cerro Los Gatos, San Dimas and Santa Elena silver mining operations in Mexico under one company.

Following the news, First Majestic's share price fell 5.1% at last look to US$5.02 in NYSE pre-market trading, while Gatos' share price jumped 7.5% to US$12.49.

Under the terms, Gatos shareholders will receive 2.55 common shares of First Majestic for each common share of Gatos held. The price implies a total offer value of US$13.49 per common share of Gatos, a 16% premium based on each company's closing prices and 20-day volume weighted average prices on the NYSE ending Sept. 4.

Following the transaction, existing Gatos shareholders will own about 38% of First Majestic shares on a fully-diluted basis.

"The acquisition of Gatos Silver ( GATO ) is a highly compelling and transformative transaction that meaningfully enhances First Majestic's operating platform through the addition of 70% of Cerro Los Gatos - a high quality, long-life, unencumbered, free cash flow generating asset in the mining-friendly state of Chihuahua, Mexico," said Keith Neumeyer, First Majestic's president and CEO.

"We are pleased to enter into this transaction with First Majestic, as it provides our shareholders an attractive immediate premium and the opportunity to retain exposure to the high quality, long-life Cerro Los Gatos asset, now within a well-established intermediate primary silver producer," Gatos CEO Dale Andres said.

The transaction is expected to close early next year.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Goldman Sachs Profit Soars As Investment Banking Fees Surge
Goldman Sachs Profit Soars As Investment Banking Fees Surge
Oct 14, 2025
Goldman Sachs Group Inc. ( GS ) shares are trading lower on Tuesday after the firm reported third-quarter results. The firm beat analyst expectations, boosted by growth across all segments. Net revenue rose 20% year over year (Y/Y) to $15.18 billion, topping the consensus estimate of $14.10 billion. Also Read: Stock Market Today: S&P 500, Nasdaq Futures Tumble Ahead Of Big Bank Earnings—Goldman Sachs, JPMorgan, Citigroup In Focus...
Goldman Sachs Profit Soars As Investment Banking Fees Surge
Goldman Sachs Profit Soars As Investment Banking Fees Surge
Oct 14, 2025
Goldman Sachs Group Inc. ( GS ) shares are trading lower on Tuesday after the firm reported third-quarter results. The firm beat analyst expectations, boosted by growth across all segments. Net revenue rose 20% year over year (Y/Y) to $15.18 billion, topping the consensus estimate of $14.10 billion. Net Interest Income surged 64% Y/Y to $3.85 billion in the quarter on a decline in funding costs and higher interest-earning assets....
Form 8.3 - Just Group plc
Form 8.3 - Just Group plc
Oct 14, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Fate Therapeutics Names Kamal Adawi as CFO
Fate Therapeutics Names Kamal Adawi as CFO
Oct 14, 2025
09:19 AM EDT, 10/14/2025 (MT Newswires) -- Fate Therapeutics ( FATE ) said Tuesday it appointed Kamal Adawi as chief financial officer, effective Monday. The company said Adawi was most recently CFO of Mindera Health. Fate Therapeutics ( FATE ) said in November that J. Scott Wolchko was to retire from his roles as president, chief executive officer, and chief...
Copyright 2023-2026 - www.financetom.com All Rights Reserved